• Guidance on sustainability and reducing the carbon footprint of respiratory care
  • Establishing the impact of exacerbations on patients with COPD
  • Introducing the next-generation propellant
Tanya Howells, Respiratory Nurse, Hywel Dda UHB
Prescribing information: TRIXEO AEROSPHERE (formoterol fumarate dihydrate / glycopyrroniumbromide / budesonide)
Prescribing information: BEVESPI AEROSPHERE (glycopyrronium bromide / formoterol fumarate dihydrate)

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App store. Adverse events should also be reported to AstraZeneca by visiting https://contactazmedical.astrazeneca.com or by calling 0800 783 0033.

This is a promotional symposium sponsored and organised by AstraZeneca and is intended for UK HCPs only.

AstraZeneca has provided a sponsorship towards this independent programme. AstraZeneca has had no editorial input into or control over the agenda, content development or choice of speakers, nor opportunity to influence except for the AstraZeneca sponsored symposia presentations.

Please note that in watching this sponsored session, the details you provide will be passed on to the sponsor for registration purposes only. You will not be contacted by the sponsor. You can learn more about how your data is handled by reviewing Cogora's and AstraZeneca’s privacy policies. If you do not wish for your details to be shared with the sponsor, please opt out by emailing data@cogora.com.

For technical support, please check the FAQs or email eventsupport@cogora.com